News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,099 Results
Type
Article (39744)
Company Profile (248)
Press Release (660107)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204192)
Career Advice (2016)
Deals (35422)
Drug Delivery (95)
Drug Development (81055)
Employer Resources (172)
FDA (16189)
Job Trends (14864)
News (345240)
Policy (32547)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49446)
ALS (95)
Alzheimer's disease (1385)
Antibody-drug conjugate (ADC) (132)
Approvals (16187)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (292)
Cancer (2322)
Cardiovascular disease (179)
Career advice (1681)
Career pathing (30)
CAR-T (156)
Cell therapy (439)
Cervical cancer (20)
Clinical research (66097)
Collaboration (857)
Company closure (2)
Compensation (569)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (251)
Cystic fibrosis (102)
Data (2337)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6382)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87078)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112676)
Executive appointments (746)
FDA (17571)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (775)
Gene editing (109)
Generative AI (20)
Gene therapy (315)
GLP-1 (719)
Government (4432)
Grass and pollen (4)
Guidances (162)
Healthcare (18820)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (98)
Interviews (316)
IPO (16530)
IRA (40)
Job creations (3633)
Job search strategy (1426)
Kidney cancer (10)
Labor market (43)
Layoffs (475)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (325)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (329)
MASH (77)
Medical device (13385)
Medtech (13390)
Mergers & acquisitions (19469)
Metabolic disorders (708)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (27)
Neuroscience (1945)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (371)
Opinion (205)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (22)
Patents (245)
Patient recruitment (116)
Peanut (46)
People (57354)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20594)
Phase II (29113)
Phase III (21678)
Pipeline (1385)
Policy (147)
Postmarket research (2563)
Preclinical (8763)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (385)
Real estate (5907)
Recruiting (65)
Regulatory (22328)
Reports (48)
Research institute (2321)
Resumes & cover letters (350)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (132)
Series B (91)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3580)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (30)
Vaccines (699)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (123)
Last 7 days (994)
Last 30 days (3247)
Last 365 days (32440)
2025 (11981)
2024 (35219)
2023 (40077)
2022 (51173)
2021 (55712)
2020 (54084)
2019 (46540)
2018 (35018)
2017 (32109)
2016 (31482)
2015 (37554)
2014 (31319)
2013 (26348)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37890)
Australia (6194)
California (6435)
Canada (2072)
China (539)
Colorado (274)
Connecticut (281)
Delaware (159)
Europe (81417)
Florida (958)
Georgia (216)
Idaho (57)
Illinois (547)
India (25)
Indiana (323)
Iowa (11)
Japan (173)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (923)
Massachusetts (4783)
Michigan (226)
Minnesota (406)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1798)
New Mexico (28)
New York (1813)
North Carolina (992)
North Dakota (8)
Northern California (2842)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1431)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (26)
South Dakota (1)
Southern California (2415)
Tennessee (106)
Texas (956)
United States (24098)
Utah (188)
Virginia (152)
Washington D.C. (64)
Washington State (566)
West Virginia (3)
Wisconsin (57)
700,099 Results for "macrogenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MacroGenics to Participate in Upcoming May 2025 Investor Conference
May 2, 2025
·
1 min read
Press Releases
MacroGenics Announces Date of First Quarter 2025 Financial Results
May 7, 2025
·
1 min read
Press Releases
MacroGenics to Participate in Upcoming Investor Conferences
February 27, 2025
·
1 min read
Press Releases
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
March 20, 2025
·
13 min read
Press Releases
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
March 7, 2025
·
1 min read
BioCapital
MacroGenics to Participate in Upcoming Investor Conferences - May 13, 2024
MacroGenics, Inc. today announced that the Company’s management will participate in the following investor conferences this month.
May 13, 2024
·
1 min read
BioCapital
MacroGenics to Participate in Upcoming June 2024 Investor Conference
MacroGenics, Inc., a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced that the Company’s management will participate in the following investor conference this month:
June 11, 2024
·
1 min read
Press Releases
MacroGenics to Participate in Upcoming Investor Conference
December 3, 2024
·
1 min read
Business
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
MacroGenics, Inc. today announced that the Company will release its financial results for the first quarter of 2024 after the market closes on Thursday, May 9, 2024.
May 3, 2024
·
1 min read
Press Releases
MacroGenics Announces Leadership Transition
October 30, 2024
·
6 min read
1 of 70,010
Next
